{
    "code": "02021207",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021207",
    "time": "2020-02-25 12:38:53",
    "許可證字號": "衛署藥輸字第021207號",
    "註銷狀態": "已註銷",
    "註銷日期": "92\/02\/24",
    "註銷理由": "賦形劑變更證別變更",
    "製造許可登錄編號": "",
    "有效日期": "95\/04\/22",
    "發證日期": "85\/04\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202120706",
    "中文品名": "顆球諾得５０",
    "英文品名": "GRANOCYTE 50",
    "適應症": "促進骨髓移植時的嗜中性白血球數的增、癌症化學療法所引起之嗜中性白血球缺乏症、伴隨著骨髓發育不良症侯群的嗜中性白血球減少症、先天性、特異性嗜中性白血球缺乏症。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶 軟管裝 安瓿附溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "92\/04\/22",
    "主成分略述": "LENOGRASTIM (GENETICAL RECOMBINATION), WATER FOR INJECTION",
    "限制項目": "02輸　入",
    "申請商名稱": "1438501100  臺灣中外製藥股份有限公司",
    "申請商地址": "台北巿中山區民生東路二段１７８．１８０號４樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0026000  USV LIMITED",
            "製造廠廠址": "5-1, UKIMA 5-CHOME, KITA-KU, TOKYO1-9, KYOBASHI 2-CHOME CHUO-KU TLKYO",
            "製造廠公司地址": "1-9, KYOBASHI 2-CHOME CHUO-KU TLKYO",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200035800",
            "成分名稱": "LENOGRASTIM (GENETICAL RECOMBINATION)",
            "含量描述": "50",
            "含量": "50.0000000000",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9604000900",
            "成分名稱": "WATER FOR INJECTION",
            "含量描述": "(PER AMPULE) 1",
            "含量": "",
            "單位": "ML"
        }
    ]
}